77014-9
LaboratoryFetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative
Definition
This term was created for, but is not limited in use to, Sequenom Laboratories' VisibiliT Trisomy 21 test, which analyzes circulating cell-free DNA extracted from maternal plasma using whole genome sequencing to determine the risk for fetal chromosome 21 aneuploidy. VisibiliT is indicated for use in pregnant women with average risk for fetal chromosomal aneuploidy.
LOINC 6-Axis Classification
Component
Fetal trisomy 21 risk
Property
Imp
Time Aspect
Pt
System
Plas.cfDNA
Scale Type
Ord
Method Type
Sequencing
Details
Class
MOLPATH.TRISOMY
Order/Observation
Observation
Short Name
Fet Ts 21 risk Plas.cfDNA Ql
Display Name
Trisomy 21 risk Sequencing Ql (cfDNA) [Interp]
Related Names
Frequently Asked Questions
What is LOINC code 77014-9?
LOINC code 77014-9 identifies "Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative". This term was created for, but is not limited in use to, Sequenom Laboratories' VisibiliT Trisomy 21 test, which analyzes circulating cell-free DNA extracted from maternal plasma using whole genome sequencing to determine the risk for fetal chromosome 21 aneuploidy. VisibiliT is indicated for use in pregnant women with average risk for fetal chromosomal aneuploidy.
What does 77014-9 measure?
This code measures Fetal trisomy 21 risk in Plas.cfDNA. It belongs to the MOLPATH.TRISOMY class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.